Summary of Key Information:
Reporting Period: Quarter ended June 30, 2026 (Q1 FY27)
Nature of Filing / Announcement: Outcome of Board Meeting - Unaudited Financial Results and Regulatory Disclosures
Audit Opinion:
Clean/Unmodified - Statutory Auditors M/s. S R Batliboi & Associates LLP issued unmodified limited review reports on both standalone and consolidated financial results.
Key Financial Highlights [₹ in Crores]:
Standalone Results:
Revenue from Operations: ₹7,743.55 (Q1 FY27) vs ₹7,001.32 (Q1 FY26) - 10.6% YoY growth
Total Income: ₹7,792.31 (Q1 FY27) vs ₹7,082.92 (Q1 FY26)
Net Profit: ₹376.96 (Q1 FY27) vs ₹508.23 (Q1 FY26) - 25.8% YoY decline
EPS: ₹12.80 (Basic) and ₹12.79 (Diluted) for Q1 FY27
Consolidated Results:
Revenue from Operations: ₹8,164.77 (Q1 FY27) vs ₹7,042.30 (Q1 FY26) - 15.9% YoY growth
Total Income: ₹8,214.58 (Q1 FY27) vs ₹7,126.04 (Q1 FY26)
Net Profit: ₹381.56 (Q1 FY27) vs ₹501.59 (Q1 FY26) - 23.9% YoY decline
Net Profit Attributable to Owners: ₹380.82 (Q1 FY27)
Non-controlling Interests: ₹0.74 (Q1 FY27)
EPS: ₹12.93 (Basic) and ₹12.92 (Diluted) for Q1 FY27
Segment-wise Performance [₹ in Crores]:
Standalone Segment Revenue:
Nutrient and other allied business: ₹6,910.49 (Q1 FY27)
Crop protection: ₹870.08 (Q1 FY27)
Total Segment Revenue: ₹7,780.57 (Q1 FY27)
Less: Inter-segment revenue: ₹37.02 (Q1 FY27)
Standalone Segment Results:
Nutrient and other allied business profit: ₹469.88 (Q1 FY27)
Crop protection profit: ₹158.81 (Q1 FY27)
Total Segment Results: ₹628.69 (Q1 FY27)
Consolidated Segment Revenue:
Nutrient and other allied business: ₹6,951.03 (Q1 FY27)
Crop protection: ₹1,250.76 (Q1 FY27)
Total Segment Revenue: ₹8,201.79 (Q1 FY27)
Less: Inter-segment revenue: ₹37.02 (Q1 FY27)
Consolidated Segment Results:
Nutrient and other allied business profit: ₹478.91 (Q1 FY27)
Crop protection profit: ₹170.15 (Q1 FY27)
Total Segment Results: ₹649.06 (Q1 FY27)
Corporate Actions:
1. Approved conversion of loan amounting to approximately ₹108 Crores to equity shares of face value ₹10/- each of Coromandel Chemicals Limited (wholly owned subsidiary) at an issue price of ₹39.95 per equity share (including premium).
2. Approved restructuring of loans amounting to USD 9.70 Million given to Baobab Mining and Chemicals Corporation S A (BMCC), a step-down subsidiary held through Coromandel Chemicals Limited, into equity or preference shares with optionality or other instruments.
Other Significant Information:
- The company acquired 53.08% voting share capital of NACL Industries Limited effective August 8, 2025, making it a subsidiary.
- During the quarter, the company allotted 32,200 equity shares (including 30,400 treasury shares) pursuant to exercise of stock options.
- The consolidated figures for Q1 FY27 may not be comparable with Q1 FY26 due to the NACL acquisition.
- Exceptional items for Q4 FY26 represented estimated provision towards impairment of investment/goodwill relating to Company's Drones subsidiary business (₹125.15 crore standalone, ₹70.56 crore consolidated).
Entities Included in Consolidation:
The consolidated results include:
- Holding Company: Coromandel International Limited
- 24 subsidiaries including Coromandel Chemicals Limited, Dare Ventures Limited, Dhaksha Unmanned Systems Private Limited, NACL Industries Limited, and various international subsidiaries
- 2 associates: Coromandel Crop Protection Inc., Philippines and Nasense Labs Private Limited
- 1 joint venture: Stuccoedge India Private Limited
Auditor Information:
Statutory Auditors: M/s. S R Batliboi & Associates LLP, Chartered Accountants
Limited review reports issued for both standalone and consolidated financial results